Neuroendocrine peptides express biologic activity relevant to the cardiovascular system, including regulating heart rate and blood pressure, though little is known about the mechanisms involved. Here we investigated neuroendocrine gene expression underlying diurnal physiology of the heart. We first used microarray and RT-PCR analysis and demonstrate the simultaneous expression of neuroendocrine genes in normal murine heart, including proopiomelanocortin (POMC), gonadotropin-releasing hormone (GnRH), neuropeptide Y (NPY), leptin receptor (ObRb), growth hormone-releasing hormone (GHRH), cocaine and amphetamine-regulated transcript (CART), proglucagon, and galanin. We examined diurnal gene expression profiles, with cosinar bioinformatics to evaluate statistically significant rhythms. The POMC gene exhibits a day/night, circadian or diurnal, pattern of expression in heart, and we postulated that this may be important to cardiac growth and renewal. POMC diurnal gene rhythmicity is altered in pressureoverload cardiac hypertrophy, as compared to control heart, and levels increased at the dark-to-light transition times. These findings are also consistent with the proposal that neuropeptides mediate adverse remodelling processes, such as occur in pathologic hypertrophy. To investigate cellular responses, we screened three cell lines representing fibroblasts, cardiac myocytes, and vascular smooth muscle cells (NIH3T3, HL-1 and Movas-1, respectively). POMC mRNA expression is most notable in Movas-1 cells, and furthermore, exhibits rhythmicity with culture synchronization. Taken together, these results highlight the diverse neuroendocrine mRNA expression profiles in cardiovasculature, and provide a novel model vascular culture system to research the role these neuropeptides play in organ health, integrity, and disease.
Introduction
The heart as an endocrine organ produces the hormone proopiomelanocortin (POMC) (Forman and Bagasra 1992) . POMC production is of particular interest, because it encodes many biologically active peptides relevant to cardiovascular physiology, such as adrenocorticotropic hormone (ACTH), -endorphin, and -and -melanocyte-stimulating hormones (MSH) (Diz and Jacobowitz 1983; Ekman, et al. 1989; Millington, et al. 1993; Millington, et al. 1999; Ni, et al. 2003; Saito, et al. 1983 ). However, little is known about POMC gene expression in the heart, and mechanisms of regulation in health and disease.
Previous studies demonstrate that >10% of cardiac genes exhibit diurnal expression patterns underlying homeostasis and pathophysiology (Martino, et al. 2004; Martino, et al. 2007a; Storch, et al. 2002; Young, et al. 2001b) . Rhythmic gene expression in the heart is believed to underlie key physiologic functions, including heart rate, blood pressure, myocardial contractile performance, carbohydrate oxidation, oxygen consumption (Muller, et al. 1985; Young, et al. 2001a) , and contribute to the timing of the onset of acute cardiac events (e.g. myocardial infarction, sudden cardiac death) (Brzezinski 1997; Charloux, et al. 1999; Haus, et al. 1989; Muller et al. 1985) . In this study, we focussed on POMC gene expression in normal murine heart, and in pressureoverload cardiac hypertrophy. In addition, we extended investigations towards additional neuroendocrine genes expressed in the vascular-derived MOVAS-1 cells. We find that POMC in particular exhibited rhythmic gene cycling similar to what is observed in the heart. Overall, these studies provide new insight into the endocrinology relevant to cardiovascular function, and further provide a novel cell model for examining the regulation of these peptides. Ultimately, these findings may translate to the clinical Page 3 of 24 setting, providing evidence for the importance of the maintenance of normal circadian rhythms, critical for heart health (Martino, et al. 2008 ).
Materials and Methods

Animals
All animal protocols were reviewed and approved by the University of Toronto Institutional Animal Care and Use Committee. Six-week-old male C57Bl/6 mice are entrained to a normal 12 h light: 12 h dark cycle (LD 12:12) for 2 weeks time. They were then subjected to surgery or sham and maintained under the normal LD 12:12 cycle, for a further 4 weeks. Animals are sacrificed by decapitation, and heart tissue collected across the 24 h diurnal cycles, as described (Martino et al. 2007a) . In a separate experiment to investigate gene expression in heart disease, pressure-overload cardiac hypertrophy was induced using a well-documented model of transthoracic aortic constriction (TAC) and compared to control (SHAM). Hearts from TAC and SHAM-operated mice were collected across the diurnal cycle, as described previously. A total of n=3 samples were collected at each time point, at 4 h intervals over 24 h, from TAC and SHAM mice, and frozen at -80°C until used.
Microarrays
Microarrays were used for global gene expression analysis, and we focussed on the expression of neuroendocrine genes in the heart. We use the Affymetrix murine GeneChips (M0E430A). Briefly, RNA is purified from heart tissue by TRIzol reagent (Invitrogen, Burlington, Canada) . Integrity and highest quality were validated by ethidium-bromide agarose gel electrophoresis, and BioAgilent spectrophotmetry. First strand cDNA synthesis, labelling, and hybridization to the microarray gene chips is performed using automated Affymetrix protocols. Scanning and per-chip normalizations were performed using MicroArray Suite version 5 (MASv5) and manufacturer specifications. GeneSpring (Agilent) was used for visualizing gene expression patterns, and also for hierarchical cluster analyses, correlations, and ontology. 24 h rhythmic gene profiles were determined by COSOPT analysis, a well-documented biocomputational program that interrogates daily gene cycling in microarray data (Martino et al. 2004; Panda, et al. 2002) . COSOPT provides an integer termed pMMC-, which denotes the statistical significance of rhythms identified.
Mouse vascular smooth muscle cell line 1 (Movas-1)
Movas-1 cells were grown in Dulbecco's Modified Eagle Medium, DMEM (SigmaAldrich, Oakville, Canada) supplemented with both 10% Fetal Bovine Serum FBS, (Hyclone; distributed by Fisher Scientific, Ottawa, Canada), and 1% penicillinstreptomycin by volume (Gibco, distributed by Invitrogen, Burlington, Canada) (Afroze, et al. 2003) . Cells are maintained in a tissue culture incubator at 37KC, 5% CO 2 . NIH3T3 cells are grown in DMEM with 10% FBS, and 1% pen-strep as described above. The Heart Line 1 (HL-1) cell line was grown in Claycomb Media, 10% FBS (by volume), with 100 µg/mL pen-strep, 0.1mM Norepinephrine and 2 mM L-Glutamine, according to the protocol previously described (Claycomb, et al. 1998) .
Analysis of POMC gene expression in Movas-1 cells
Movas-1 cells were plated to confluence in 60 mm 2 tissue culture dishes and grown to confluency overnight (12-16 h) (Falcon, distributed by VWR, Mississauga, Canada). For control or baseline values, the cells were scraped from the plates using a plastic scraping tool, every 4 h for 24 h. RNA was isolated using the guanidium-thiocyanate phenol chloroform extraction method (Chomczynski and Sacchi 1987) , and quantified via spectrophotometry to determine concentration and to demonstrate high quality purification. For experiments examining gene rhythmicity in vitro, confluent cells were first starved in serum free media (supplemented with 5% penicillin-streptomycin) for 12 h. Cells were then serum shocked with 20% FBS for 30 min. Serum shock is currently the standard method used to synchronize cells in culture (Hurst, et al. 2002; Young 2006) .
Following serum shock, cells were returned to normal culture conditions, and samples collected every 4 h for 36 h. Expression was determined by RT-PCR, as opposed to microarray.
Semi-quantitative Reverse Transcription (RT)-PCR
Gene expression patterns in the microarray data, and the Movas-1 cells, were both further confirmed by reverse transcription polymerase chain reaction (RT-PCR) using the One-
Step RT-PCR kit (Qiagen, Mississauga, Canada) according to manufacturer instructions.
See Table 1 
Results
Neuroendocrine genes in the heart
We first investigated expression of neuroendocrine genes in the normal murine heart. We detected expression of proopiomelanocortin (POMC), gonadotropin-releasing hormone (GnRH), neuropeptide Y (NPY), leptin receptor (ObRb), growth hormone-releasing hormone (GHRH), cocaine and amphetamine-regulated transcript (CART), proglucagon (ProGlu), and galanin genes in the heart by microarray analysis, and subsequently verified these results using RT-PCR. Hypothalamic RNA was used as a control (Figure 1 ).
POMC Gene Expression in Heart is Circadian
We examined the neuroendocrine genes for cosinar rhythms using COSOPT analysis, a well-documented biocomputational program that interrogates daily gene cycling in microarray data (Martino et al. 2004; Panda, et al. 2002) , in normal (sham operated) mouse hearts. The POMC gene profile exhibited a robust rhythm over 24 h diurnal cycles, both by microarray analyses (Figure 2A The trough of POMC expression occurs during the day, approximately 4-7 h following lights on (ZT 4-7) (subjective night or sleep).
Aortic Constriction Alters POMC Gene Expression Profile
We next examined POMC gene expression in heart disease. We performed a parallel microarray study, but used mice subject to aortic-constriction induced cardiac hypertrophy, versus sham-operated controls. As shown in Figure 3 , the Sham mice exhibited the same expression profile as our control mice from the first experiment above, thus validating the methods used. Remarkably, POMC gene expression in TAC mice phase shifted relative to the sham control mice. That is, in contrast to normal heart, the peak for cardiac POMC expression in hypertrophied heart occurred approximately 8 h after lights off (ZT=20) Additionally significant differences were observed in the overall levels of POMC mRNA expression in cardiac hypertrophy, at ZT 3 and ZT 22 (*=p<0.05) (Figure 3) .
Expression of neuroendocrine genes in Movas-1 Cells
We studied a pure heart-derived cell culture system, which can be used to examine diurnal neuroendocrine gene expression in vitro. These cell lines do not have any sympathetic neuronal cell types that may be present when isolating the entire heart for analysis. We screened three cell lines representative of cardiac-derived cells; immortalized murine vascular smooth muscle cells (Movas-1), murine fibroblasts Table 2 . It should be noted that the primer set used to amplify the POMC mRNA in the Movas-1 cells detects the full length POMC mRNA and not the truncated form (Millington et al. 1999 ). This full length POMC mRNA includes a region coding for a signal peptide that ensures translation of the transcript into protein. 
Discussion
In this study, we describe a group of neuroendocrine genes expressed in murine heart, based on microarray and RT-PCR data. These included GHRH, CART, ProGlu, and galanin, which have never before been investigated in heart tissue, along with GnRH, NPY, POMC, and the long, active form of leptin receptor (ObRb) mRNA. These findings add significantly to a growing list of neuroendocrine genes and products relevant to the cardiovascular system. We next examined the diurnal expression pattern of these genes in hearts from both control and TAC mice. We found that in the heart, the only gene with a distinct and significant diurnal rhythm was POMC (Supplemental Figure 1) . Therefore, we focussed on this gene for the remainder of our study.
The POMC gene produces peptides previously localized to cardiocytes by immunohistochemical analyses (Diz and Jacobowitz 1983; Ekman et al. 1989; Millington et al. 1993; Millington et al. 1999; Ni et al. 2003; Saito et al. 1983 ). Here we confirmed these findings and demonstrated that not only is it encoded by cardiac cells with a panel of other neuroendocrine genes, but also that the POMC gene expression exhibited a rhythmic profile consistent with the 24 h period. We postulated that as such, POMC gene expression underlies physiology relevant to the cardiovascular system.
We next investigated POMC expression in vitro, and provided evidence for a new model system for investigating relevant cell mechanisms. To do this, we screened several cell lines that represent different cell types found collectively in the heart. We examined the Movas-1 (vascular myocyte) cell line, the NIH3T3 (fibroblast) line, and the HL-1 (cardiomyocyte) line. Movas-1 was the only cell type to express POMC mRNA, and in addition the cells also were positive for AgRP, galanin, ObRb, TPH, proGlu, and GnRH.
Furthermore, we demonstrated using serum shock synchronization that POMC gene expression was rhythmic in Movas-1 cells. It is particularly interesting to observe rhythmicity in this key neuroendocrine gene outside of the brain. The profile of POMC expression in these cells closes mimics the pattern of BMAL1 (Chalmers JA 2008, submitted). As BMAL1 gene expression in the brain and other tissues is regulated by several other circadian transcription factors, further work is required to first determine if the clock directly controls POMC expression, and if so, which of these regulators is responsible (Reppert and Weaver 2001, 2002) . The existence of E-box binding sites in the promoter region of the POMC gene (Figure 4) , lends further support to the hypothesis of transcriptional regulatory control similar to that found in the brain and points to avenues of future direction (Monnet, et al. 1981; O'Donohue, et al. 1979a; O'Donohue, et al. 1979b; Scimonelli, et al. 1987 ).
Peripheral tissues, such as the heart, and also cell lines representative of nonneuronal tissues, express a remarkable collection of neuroendocrine genes. The regulation of these genes is likely important in organ structure and function, and further analysis of their role in cardiovascular endocrinology is warranted. For example, the peptide product -MSH, a natriuretic peptide derived from POMC, is actively investigated for its role in regulating a variety of cardiovascular functions, most notably affects on heart rate and blood pressure. This peptide is commonly thought to exert its cardiovascular action via the melanocortin 3 receptor (MC3R), which binds with high selectivity and affinity in the anteroventral third ventricle (AV3V) region of the brain.
We speculate that diurnal profiles of POMC mRNA synthesis, and peptide production, can facilitate the heart rate and blood pressure increase that occurs normally in the subjective day or active period, and the decrease at night or sleep period. Further support for this notion of diurnal availability of POMC for cardiovascular processes comes from findings that -MSH administered in the CNS stimulates sympathetic outflow, increases mean arterial pressure, and produces tachycardia in most (Gruber and Callahan 1989; Schioth 2001; Wikberg, et al. 2000) , but not all (De Wildt, et al. 1993; De Wildt, et al. 1994) reports. Moreover, Ni et al. present evidence of a hypotensive role for -MSH in salt-sensitive hypertensive mice (Ni et al. 2003) , further supporting our hypothesis.
We observed a shift in the POMC diurnal gene expression profile in pressure-overload murine heart. The mechanism by which this occurs is not clear. One possibility is the underlying cell circadian mechanism. However, our previous studies demonstrated that the core clock genes (per2, bmal, rev-erb, etc) and overall phase of rhythmicity in TAC heart do not change as compared to sham (Martino et al. 2007a; Young et al. 2001b) . A more likely possibility is derived from the significant increase in blood pressure; this may contribute to the altered POMC expression profile in much the same manner as the matrix remodelling genes, which also change expression profiles in hypertrophic heart vs. sham. Also, there is small vessel hyperplasia in heart along with perivascular fibrosis, a compensatory response to the high-pressure environment due to the aortic ligature. This observation of vasculopathy, in combination with the rhythmic expression of POMC gene expression in vascular myocytes (Movas-1) in vitro, provides a basis for the changes that occur. Lastly, there are very recent investigations by our group and others examining the diurnal proteome in peripheral organs (Martino, et al. 2007b; Reddy, et al. 2006 ). An interesting future experiment would be to determine which POMC-derived products are produced at differing times in the heart, and how this changes in heart disease. Use of in vivo Langendorff could further provide information on the effects that occur in the day versus night, as well as responses to inhibitors given at specific times across the diurnal cycle.
In summary, we show here expression of important neuroendocrine genes in the mammalian heart. Many of their gene products are involved in regulatory processes vital for cardiovascular physiology. In neural tissues their timing of expression is presumed to underlie physiology, and thus we hypothesize a similar temporal role in peripheral tissues, such as the heart. We detect diurnal profiles of neuroendocrine genes expressed in normal heart. That diurnal profiles are also observed in heart disease, and specifically that POMC expression changes with the development of pathologic hypertrophy, provides intriguing evidence for a potential role of circadian dysregulation in disease.
We also investigated the non-neural cellular regulation of these genes, and demonstrated clear and reproducible expression in vascular myocytes in vitro. Culture synchronization by serum shock established a rhythmic gene phenotype in vitro, and is consistent with neuroendocrine rhythms in the murine heart in vivo. These studies may shed new light and understanding on gene expression patterns underlying cardiovascular physiology and pathology, and present novel avenues for future research in heart disease. 
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